EyePoint Pharmaceuticals (EYPT) Assets: 2011-2019
Historic Assets for EyePoint Pharmaceuticals (EYPT) over the last 8 years, with Mar 2019 value amounting to $81.9 million.
- EyePoint Pharmaceuticals' Assets rose 63.19% to $81.9 million in Q1 2019 from the same period last year, while for Mar 2019 it was $81.9 million, marking a year-over-year increase of 63.19%. This contributed to the annual value of $71.7 million for FY2018, which is 283.73% up from last year.
- According to the latest figures from Q1 2019, EyePoint Pharmaceuticals' Assets is $81.9 million, which was up 4.72% from $78.2 million recorded in Q4 2018.
- EyePoint Pharmaceuticals' 5-year Assets high stood at $88.9 million for Q3 2018, and its period low was $13.3 million during Q3 2017.
- Moreover, its 3-year median value for Assets was $50.2 million (2018), whereas its average is $48.3 million.
- Per our database at Business Quant, EyePoint Pharmaceuticals' Assets plummeted by 51.60% in 2017 and then skyrocketed by 566.73% in 2018.
- Over the past 5 years, EyePoint Pharmaceuticals' Assets (Quarterly) stood at $23.9 million in 2015, then dropped by 17.55% to $19.7 million in 2016, then decreased by 28.10% to $14.2 million in 2017, then soared by 450.60% to $78.2 million in 2018, then spiked by 63.19% to $81.9 million in 2019.
- Its Assets was $81.9 million in Q1 2019, compared to $78.2 million in Q4 2018 and $88.9 million in Q3 2018.